Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 1;102(6):1879-1888.
doi: 10.1210/jc.2016-3569.

Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study

Edward Yu  1 , Miguel Ruiz-Canela  2   3 , Frank B Hu  1   4   5 , Clary B Clish  6 , Dolores Corella  3   7 , Jordi Salas-Salvadó  3   8 , Adela Hruby  9 , Montserrat Fitó  3   10 , Liming Liang  11 , Estefanía Toledo  2   3 , Emilio Ros  3   12 , Ramón Estruch  3   13 , Enrique Gómez-Gracia  3   14 , José Lapetra  3   15 , Fernando Arós  3   16 , Dora Romaguera  3   17 , Lluís Serra-Majem  3   18 , Marta Guasch-Ferré  1 , Dong D Wang  1 , Miguel A Martínez-González  1   2   3
Affiliations

Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study

Edward Yu et al. J Clin Endocrinol Metab. .

Abstract

Context: Arginine, its methylated metabolites, and other metabolites related to the urea cycle have been independently associated with cardiovascular risk, but the potential causal meaning of these associations (positive for some metabolites and negative for others) remains elusive due to a lack of studies measuring metabolite changes over time.

Objective: To examine the association between baseline and 1-year concentrations of urea cycle metabolites and cardiovascular disease (CVD) in a case-cohort setting.

Design: A case-cohort study was nested within the Prevención con Dieta Mediterránea trial. We used liquid chromatography-tandem mass spectrometry to assess metabolite levels at baseline and after 1-year follow-up. The primary CVD outcome was a composite of myocardial infarction, stroke and cardiovascular death. We used weighted Cox regression models (Barlow weights) to estimate multivariable-adjusted hazard ratios (HRs) and their 95% confidence intervals (CIs).

Setting: Multicenter randomized trial in Spain.

Participants: Participants were 984 participants accruing 231 events over 4.7 years' median follow-up.

Main outcome measure: Incident CVD.

Results: Baseline arginine/asymmetric dimethylarginine ratio [HR per standard deviation (SD) = 0.80; 95% CI, 0.67 to 0.96] and global arginine availability [arginine / (ornithine + citrulline)] (HR per SD = 0.83; 95% CI, 0.69 to 1.00) were significantly associated with lower risk of CVD. We observed no significant association for 1-year changes in these ratios or any effect modification by the Mediterranean diet (MD) intervention.

Conclusions: A higher baseline arginine/asymmetric dimethylarginine ratio was associated with lower CVD incidence in a high cardiovascular risk population. The intervention with the MD did not change 1-year levels of these metabolites.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Diagram of the urea cycle, NOS, and degradation of arginine.
Figure 2.
Figure 2.
Correlation coefficient heat map of metabolites under study. All correlation coefficients had P values < 0.0001.
See this image and copyright information in PMC

References

    1. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104(22):2746–2753. - PubMed
    1. Shah SH, Kraus WE, Newgard CB. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation. 2012;126(9):1110–1120. - PMC - PubMed
    1. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113(13):1708–1714. - PubMed
    1. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol. 2001;64(4):365–391. - PubMed
    1. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336(Pt 1):1–17. - PMC - PubMed

Publication types

MeSH terms